semaglutide inflammation Semaglutide does more than reduce appetite—it works across several organs that influence metabolic health. Clinical studies show that semaglutide can: 🧠 Improve appetite regulation through brain pathways 🩸 Reduce inflammation within the

NEW EPISODE: RetatrutideThe Triple Agonist *Not licensed* Will this replace the current GLP 1 in the market. This triple receptor agonist (GIP GLP 1 glucagon) is showing unprecedented results in weight loss trials, outperforming current VISION RISKS: The American Optometric Association issued a bulletin earlier this year stating that GLP 1 drugs have been associated with non arteritic anterior ischemic optic neuropathy, a condition that causes sudden, painless vision Retatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed the Godzilla of weight loss jabs because of its potential superior efficacy. Developed by Eli Lilly, retatrutide is a triple hormone The FDA has approved Foundayo, a new oral GLP 1 receptor agonist from Eli Lilly, built on a non peptide small molecule called orforglipron rather than a traditional peptide structure. Across clinical trials, it switching to retatrutide from tirzepatide Tirzepatide vs Retatrutide , 2 powerful weight loss treatments changing Ticker: Hims & Hers drops plans for knockoff weight loss pill; Washington Post editor steps down